The limits of insulin pump treatment

Sources verified Updated: September 7, 2026 9 min read

An insulin pump brings better blood glucose control, but it also comes with some risks, such as technical malfunctions, interruptions of insulin delivery, skin irritation and higher costs.

3 kinds of limits
technical, personal and cost-related
occlusion alarm
most pumps warn you when insulin stops flowing
training first
the main condition for safe use

What are the limits of pump treatment?

The pump brings many advantages, but it also has a few limits that are worth knowing. It uses a single type of insulin, rapid-acting, and delivers your insulin through a thin cannula placed under the skin [1]. Being a device, it can develop technical problems at any time and it needs maintenance. In addition, the pump is worn almost all the time.

The second limit comes from you, not from the device. The pump requires you to learn how it works and to react quickly when an alarm or a problem appears [2]. Costs can be higher, and some people do not feel comfortable wearing a device attached to their body. These limits do not mean that the pump is a poor choice, but that it has to be used carefully and with good training, as the figure below shows.

Figure 1

The four limits of pump treatment

  1. It is the deviceA device can go wrongThe pump uses a single type of insulin, rapid-acting, and it needs maintenance.
  2. It is youIt asks for learning and quick reactionsYou have to know how it works and react when an alarm or a problem comes up.
  3. It is the wearingIt is worn almost all the timeSome people do not feel comfortable with a device attached to the body.
  4. It is the costThe expense can be higherOn top of the pump come the supplies, compared with treatment by pen.
The pump delivers insulin through a thin cannula placed under the skin and, being a device, can always run into technical trouble [1]. The second limit is about you, not the device. The pump asks you to learn how it works and to react quickly [2]. These limits do not make the pump a poor choice, only one that is used with care.

What happens if the pump breaks down?

A modern pump is built to warn you when something is not working properly. If a malfunction appears, the device usually gives an audible alarm or vibrates and displays a message, so that you know that insulin delivery has stopped [3]. In this way you have time to take action before blood glucose rises too much.

If the pump can no longer be used, the backup plan is to give yourself insulin with the injector pen until you solve the problem. The syringe remains an option, although it is used less often nowadays. That is why it is important to always have spare insulin and injection supplies at hand [4]. The medical team will explain to you which doses to use in this situation.

Why can insulin delivery be interrupted?

Insulin delivery can stop for several practical reasons. Most often, the infusion set can become blocked or kinked, and the cannula can move out of place [5]. The reservoir can empty, the battery can run down, and sometimes a technical problem of the device appears [6].

At other times the insulin is not absorbed properly, because the cannula was placed in an area with thickened subcutaneous tissue [7]. Any of these situations can stop insulin delivery, sometimes for hours on end and without you realizing it [8]. The good news is that most pumps detect blockages and warn you through an alarm [6].

Does the risk of ketone bodies increase on the pump?

Yes, ketone bodies, acidic substances produced when it burns fat in the absence of insulin, can appear faster with pump treatment than with injections. The reason is that the pump uses only rapid-acting insulin and does not create a subcutaneous depot of long-acting insulin. If delivery stops, the body is left without insulin within a very short time [9].

Without insulin, at some point the body starts to produce ketone bodies, and these can build up in only a few hours [10]. When they accumulate in large amounts, diabetic ketoacidosis develops, a medical emergency that has to be treated in hospital.

That is why, if blood glucose is high and does not come down, it is good to check the infusion set and to measure your ketones with urine ketone strips or with a blood ketone meter. Then give yourself insulin with the injector pen. Taken in good time, these measures reduce the risk considerably, though they do not remove it completely. If blood ketones are between 1.5 and 2.9 mmol/L, contact the medical team immediately. At 3.0 mmol/L or above, or if vomiting, difficulty breathing or drowsiness appear, go to the emergency room straight away.

Do I have to wear the pump all the time?

Most of the time, yes. The pump continuously delivers small amounts of basal insulin, which the body needs all the time, day and night. If you take it off for a long time, this delivery stops and blood glucose can rise [11].

You can disconnect it for short periods, for example in the shower, when swimming or during a contact sport [12]. What matters is that the pause does not exceed one hour and that you give yourself the missing insulin if it does run longer, according to the protocol agreed with your medical team. In this way you enjoy flexibility without your blood glucose rising too much.

Does the pump require more attention every day?

The pump does not really work on its own. It needs your daily involvement. You have to count carbohydrates, ask for the boluses at meals, follow blood glucose or the sensor values and respond to alarms [13].

Every few days you have to change the infusion set. In between, it is good to check the insulin level in the reservoir and the state of the battery [7]. This extra attention compared with injections may seem like too much at the beginning, but it becomes a simple routine once you get used to it. In exchange, you gain finer blood glucose control [14].

Can wearing the pump irritate my skin?

Yes, the skin in the area where you wear the cannula and the adhesive patch can sometimes become red, irritated or tender [15]. The adhesive, sweat and rubbing can cause itching or a small local reaction. In some people, repeated use of the same site leads to thickening of the subcutaneous tissue through local deposition of excess fat (lipohypertrophy) [7].

These problems can be reduced considerably if you regularly change the cannula site and clean the skin well before applying it. If redness that does not go away, pain or signs of infection appear, tell the medical team [16]. Changing the cannula site in good time removes most irritations.

Is pump treatment more expensive?

In general, yes. The pump is a more expensive device compared with injector pens. Besides the device itself (the pump), you also need consumables, which are changed regularly, such as infusion sets and reservoirs. To these can be added the batteries and, if you use a pump integrated with a sensor, the cost of the sensors [17].

The cost for you depends very much on how these devices are covered by medical insurance (state or private) in the country where you live. It is worth discussing the expenses with the medical team early on, so that you know what to expect. For most patients the benefits for glycemic control justify this cost [14] [17].

Can there be situations in which the pump does not suit me?

Yes. The pump is a very good device, but it is not the ideal choice for everyone. Some people do not feel comfortable wearing a device attached to their body. Others prefer the simplicity of injections or do not want to manage a fairly technical piece of equipment such as the pump every day [18].

Your own preference is, in itself, reason enough not to choose the pump. Perhaps you do not want to count carbohydrates, to respond to alarms or to change the infusion set regularly. The choice of the method of insulin delivery belongs to you, together with your medical team. If the pump does not suit you now, you can go back to injections at any time or you can try the pump later.

Do I need special training to use the pump safely?

Yes, and this is one of the most important conditions for using the pump safely. The pump is a technical device. Before using it, you learn from the medical team how to program it, how to ask for the boluses and how to change the infusion set [19].

The training you receive at the start of pump treatment also teaches you how to recognize a problem. You learn what to do when an alarm appears or when blood glucose rises for no apparent reason. You will know when to switch to the injector pen and how to avoid the build-up of ketone bodies [4]. With good training and the support of the medical team, using the pump becomes safe and easy.

Conclusions

  • The pump uses a single type of insulin, rapid-acting, without a subcutaneous depot of slow insulin, so any unexpected stop leaves you without insulin within a very short time [1] [9].
  • The most frequent causes of interruption are a blocked or kinked infusion set, a displaced cannula, an empty reservoir and a flat battery [5] [6] [8].
  • If you are left without insulin, ketone bodies can appear within a few hours, which is why the backup plan with the injector pen must always be at hand [4] [10].
  • Skin irritation and lipohypertrophy are greatly reduced by changing the cannula site regularly and by cleaning the skin before applying it, though they do not disappear completely [7] [15] [16].
  • The higher cost and the initial complexity of pump treatment are real, but they are offset by better glycemic control, and in the end the choice remains yours, together with your medical team [13] [14] [17] [18].

You might also be interested in

Other pages about the basics of insulin pump technology.

Glossary terms used here

References

  1. American Diabetes Association Professional Practice Committee. 7. Diabetes Technology: Standards of Care in Diabetes-2026. Diabetes Care. 2026;49(Suppl 1):S150-S165. PubMed
  2. Heinemann L, Fleming GA, Petrie JR, Holl RW, Bergenstal RM, Peters AL. Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting and research needs. A joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group. Diabetologia. 2015;58(5):862-870. PubMed
  3. Guenego A, Bouzillé G, Breitel S, et al. Insulin Pump Failures: Has There Been an Improvement? Update of a Prospective Observational Study. Diabetes Technol Ther. 2016;18(12):820-824. PubMed
  4. Meade LT, Rushton WE. Optimizing insulin pump therapy: a quality improvement project. Diabetes Educ. 2013;39(6):841-847. PubMed
  5. Waldenmaier D, Zschornack E, Buhr A, et al. A Prospective Study of Insulin Infusion Set Use for up to 7 Days: Early Replacement Reasons and Impact on Glycemic Control. Diabetes Technol Ther. 2020;22(10):734-741. PubMed
  6. Estock JL, Codario RA, Keddem S, Zupa MF, Rodriguez KL, DiNardo MM. Insulin Pump-Associated Adverse Events: A Qualitative Descriptive Study of Clinical Consequences and Potential Root Causes. Diabetes Technol Ther. 2023;25(5):343-355. PubMed
  7. Deeb A, Abdelrahman L, Tomy M, et al. Impact of Insulin Injection and Infusion Routines on Lipohypertrophy and Glycemic Control in Children and Adults with Diabetes. Diabetes Ther. 2019;10(1):259-267. PubMed
  8. Hughes MS, Douvas JL, Layfield-Bryan M, et al. Frequency and Detection of Insulin Infusion Site Failure in the Type 1 Diabetes Exchange Online Community. Diabetes Technol Ther. 2023;25(6):426-430. PubMed
  9. Aiello EM, Laffel LM, Patti ME, Doyle FJ 3rd. Ketone-Based Alert System for Insulin Pump Failures. J Diabetes Sci Technol. 2025;19(3):683-691. PubMed
  10. Klonoff DC, Ayers AT, Ho CN, et al. Time to Moderate and Severe Hyperglycemia and Ketonemia Following an Insulin Pump Occlusion. J Diabetes Sci Technol. 2024;18(6):1472-1479. PubMed
  11. Zisser H. Quantifying the impact of a short-interval interruption of insulin-pump infusion sets on glycemic excursions. Diabetes Care. 2008;31(2):238-239. PubMed
  12. Franc S, Daoudi A, Pochat A, et al. Insulin-based strategies to prevent hypoglycaemia during and after exercise in adult patients with type 1 diabetes on pump therapy: the DIABRASPORT randomized study. Diabetes Obes Metab. 2015;17(12):1150-1157. PubMed
  13. Tanenbaum ML, Commissariat PV. Experience with burdens of diabetes device use that affect uptake and optimal use in people with type 1 diabetes. Endocr Connect. 2023;12(10):e230193. PubMed
  14. Bojoga I, Ioacara S, Malinici E, et al. Enhanced Metabolic Control in a Pediatric Population with Type 1 Diabetes Mellitus Using Hybrid Closed-Loop and Predictive Low-Glucose Suspend Insulin Pump Treatments. Pediatr Rep. 2024;16(4):1188-1199. PubMed
  15. Kalus A, Shinohara MM, Wang R, et al. Evaluation of Insulin Pump Infusion Sites in Type 1 Diabetes: The DERMIS Study. Diabetes Care. 2023;46(9):1626-1632. PubMed
  16. von Kobyletzki LB, Ulriksdotter J, von Kobyletzki E, Mowitz M, Jendle J, Svedman C. Insulin Pump Therapy and Adverse Skin Reactions With Focus on Allergic Contact Dermatitis in Individuals Living With Diabetes Mellitus: A Systematic Review and Clinical-Based Update. J Diabetes Sci Technol. 2024;18(6):1300-1312. PubMed
  17. Roze S, Smith-Palmer J, Valentine W, de Portu S, Nørgaard K, Pickup JC. Cost-effectiveness of continuous subcutaneous insulin infusion versus multiple daily injections of insulin in Type 1 diabetes: a systematic review. Diabet Med. 2015;32(11):1415-1424. PubMed
  18. Dekker P, Aanstoot HJ, Sas T, et al. Prevalence of and Reasons for Discontinuation of Continuous Subcutaneous Insulin Infusion in People with Type 1 Diabetes: A Systematic Review. Diabetes Technol Ther. 2023;25(8):559-570. PubMed
  19. Rytter K, Schmidt S, Rasmussen LN, Pedersen-Bjergaard U, Nørgaard K. Education programmes for persons with type 1 diabetes using an insulin pump: A systematic review. Diabetes Metab Res Rev. 2021;37(5):e3412. PubMed